Skip to main content

Merit Financial Group, LLC

Position in LLY — ELI LILLY & Co

CIK 1621225 ALPHARETTA, GA

Position in LLY

as of Jun 30, 2026 · filed Jul 20, 2026
Position Value
$55,033,445
+$14,969,187 QoQ
Shares Held
45,883
+5.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.99%
of 13F equity value
Holder Rank
#523
of 4,605 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Derivatives in LLY

reported options exposure · as of Dec 31, 2025
CallValue
$647,840
CallShares
800
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Merit Financial Group, LLC holds $230,161,066 across 16 Drug Manufacturers - General names. LLY ranks #1 (23.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
This page
45,883 $55,033,445

All Filings in LLY

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $55,033,445 45,883
2026-03-31 $40,064,258 43,559
2025-12-31 $40,874,379 38,034
2025-12-31 $647,840 800
2025-09-30 $26,299,847 34,469
2025-06-30 $25,280,157 32,430
2025-03-31 $20,898,000 25,303
2024-12-31 $15,865,372 20,551
2024-09-30 $12,619,329 14,244
2024-06-30 $14,137,508 15,615
2024-03-31 $10,161,713 13,062
2023-12-31 $2,642,959 4,534
2023-09-30 $5,133,888 9,558
2023-06-30 $4,372,769 9,324
2023-03-31 $2,644,334 7,700
2022-12-31 $2,231,258 6,099
2022-09-30 $1,589,588 4,916
2022-06-30 $2,919,691 9,005
2022-03-31 $210,481 735